Discovery of New Biomarkers to Expand Scope of Immunoprotein Diagnostic Testing, reports TMR The global immunoprotein diagnostic testing market is led by many global giants. Some of the players operating in the market are Abbott Laboratories, Inc., Abcam PLC, Enzo Life Sciences, Inc., DiaSorin SPA, and Fujirebio Diagnostics, Inc. The distributors in the market, supply products for more than one company. A few substitutes in the market such as molecular diagnostics and microbiology assay are available, but with their own disadvantages. Thus, the threat of substitutes is expected to be low, states a new report by Transparency Market Research (TMR). High entry barriers such as compliance to regulations and huge capital requirements exist in the immunoprotein diagnostic testing market. However, the threat of new entrants is still expected to be moderate as many new players offer OEM services to the leading players in the market. These small companies can enter the market easily through forward integration.
According to the report, the global immunoprotein diagnostic testing market is expected to be worth US$15.35 bn by 2019. On the basis of assay technology used, the enzyme-based immunoassay segment is expected to lead in the market in the coming years. The market for enzyme-based immunoassay is projected to be worth US$5.34 bn by 2019. North America to Lead Market owing to Need for Quick Diagnostic Services for Viral Infections and Cancer By geography, North America is expected to lead in the market and be worth US$6.07 bn by 2019. The market in the region is driven by the demand for quick diagnostic services for viral infections and cancer. The rising trend of preventive healthcare is also creating new opportunities for the market in North America. Additionally, increasing cases of drug abuse and allergies have become major concerns in the U.S., which are further driving the demand for immunoprotein diagnostic testing. Read Full Report: http://www.transparencymarketresearch.com/immunoprotein-diagnostictesting.html By immunoprotein type, the immunoglobulin diagnostic tests segment is expected to lead in the global market in the coming years. The global market for immunoglobulin diagnostic testing is expected to be worth US$4.7 bn by 2019 owing to a wide scope of application in infectious disease testing, allergy testing, and autoimmune testing.
Rising Prevalence of Diseases to Create Need for Immunoprotein Diagnostic Testing The rising prevalence of malaria, hepatitis, typhoid, HIV, tuberculosis, and cancer across the globe is driving the global immunoprotein diagnostic testing market. “Many of the diseases have a higher prevalence in underdeveloped economies,” states a TMR analyst. Thus, the demand for low cost, yet effective diagnostic tests is particularly high in underdeveloped nations. A need to diagnose diseases at an earlier stage to avoid severe complications is leading to an increased demand for immunoprotein diagnostic testing kits. Besides this, the market is gaining impetus from technological innovations. Advancements in technology have helped reduce the amount of sample required for tests and also enabled testing for multiple biomarkers in a single assay, reducing the cost per test. High Cost of Diagnosis Dampening Demand for Immunoprotein Diagnostic Testing Due to economic crisis, governments of countries such as Germany, France, Spain, Italy, and Hungary have cut down on reimbursement rates, which is increasing the out of pocket expenses of patients. This is limiting the adoption of immunoprotein diagnostic testing. Additionally, the low per capita income of people in many countries have led patients to look for cost effective alternatives for diagnosis. These factors are expected to dampen the demand for immunoprotein diagnostic testing. Immunochromatography-based Cassette Kits to Emerge as Opportunity for Growth in Market After the modification of the Clinical Laboratory Improvement Amendments (CLIA) waiver policies, the FDA has approved tests for home use. This has hugely benefitted the home diagnostics market, which is led by immunochromatography-based cassette kits such as pregnancy detection kits, HIV, malaria, and drug abuse testing kits. Additionally, the over-thecounter sale and wide availability of immunochromatography-based cassette kits are expected to drive the market further. An increased investment in R&D in order to expand the application of the available technologies have led to the introduction of newer products. This has also led to the discovery of new biomarkers such as free light chains, which is acting as an opportunity to expand the scope of market. This information is based on the findings of a report published by Transparency Market Research titled “Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 - 2019.” The global immunoprotein diagnostic testing market is segmented as follows: Assay Technology
• Radioimmunoassay • Enzyme Based Immunoassay • Chemiluminescence Assay • Immunofluorescence Assay • Immunoturbidity Assay • Immunoprotein Electrophoresis Immunoprotein Type • Complement System Proteins Diagnostic Tests • Free Light Chain Diagnostic Tests • Haptoglobin Diagnostic Tests • Immunoglobulin Diagnostic Tests • Prealbumin Diagnostic Tests • C-Reactive Protein (CRP) Diagnostic Tests Application • Infectious Disease Testing • Oncology Testing • Endocrine Testing • Toxicology Testing • Allergy Testing • Autoimmune Disease Testing Geography • • • •
North America Europe Asia Pacific Rest of the World
About Us Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com